Literature DB >> 19515882

Hospital outcome of coronary artery bypass grafting and coronary endarterectomy.

Abdul R Abid1, Ajwad Farogh, Mumraiz S Naqshband, Raja P Akhtar, Jawad S Khan.   

Abstract

To compare hospital mortality and postoperative complications in patients with severe coronary artery disease undergoing coronary artery bypass grafting with or without coronary endarterectomy, 100 consecutive patients were divided into 2 groups of 50 patients each. Group 1 had coronary endarterectomy, and group 2 had no coronary endarterectomy. There were 87 men and 13 women, with a mean age of 54.79 +/-7.8 years; 48% had stable angina. The right coronary artery was endarterectomized in 22 patients, the left anterior descending artery in 21, and the left circumflex in 7. There were no significant differences in outcomes. There was 1 hospital death in each group. Perioperative myocardial infarction occurred in 2 patients in group 1 and 1 in group 2. Endarterectomy is a suitable option to achieve complete revascularization in patients with refractory angina and severe diffuse disease.

Entities:  

Mesh:

Year:  2009        PMID: 19515882     DOI: 10.1177/0218492309102609

Source DB:  PubMed          Journal:  Asian Cardiovasc Thorac Ann        ISSN: 0218-4923


  3 in total

1.  Association of cardiac enzymes with morbidity and mortality of patients undergoing coronary endarterectomy surgery.

Authors:  Aghigh Heydari; Feridoun Sabzi; Atefeh Asadmobini; Soudabeh Eskandari
Journal:  ARYA Atheroscler       Date:  2021-11

2.  Outcome and graft patency in coronary artery bypass grafting with coronary endarterectomy.

Authors:  Mohammad Hassan Nemati; Behrooz Astaneh; Shahdad Khosropanah
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2015-02-05

3.  Short- and Long-Term Patient Outcomes From Combined Coronary Endarterectomy and Coronary Artery Bypass Grafting: A Meta-Analysis of 63,730 Patients (PRISMA).

Authors:  Jiayang Wang; Chengxiong Gu; Wenyuan Yu; Mingxin Gao; Yang Yu
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.